PITTSBURGH–(BUSINESS WIRE)–Noveome Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation biologics for the promotion and restoration of cellular integrity of inflamed or damaged tissues, today announc…
Category: Business
Aerie Pharmaceuticals to Present at Two Upcoming Investor Conferences
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Jon Morgan Joins Eyecare Services Partners as Chief Information Officer
DALLAS–(BUSINESS WIRE)–Eyecare Services Partners (ESP), the national leader in integrated eye care services, announced the appointment of Jon Morgan as Chief Information Officer effective today. Mr. Morgan leads Information Technology for ESP, which …
Rick Hoffner Joins Eyecare Services Partners as Vice President of Operations, Central Region
DALLAS–(BUSINESS WIRE)–Eyecare Services Partners (ESP), the national leader in integrated eye care services, announced the appointment of Rick Hoffner as Vice President of Operations for the Central Region, effective today. Mr. Hoffner will lead the …
Aerpio Initiates Phase 1b Clinical Trial of Topical Ocular Formulation of AKB-9778 for Primary Open Angle Glaucoma
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today announced dosing of the first subject in…
NovaBay Pharmaceuticals Launches Avenova® Direct on Amazon.com
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova® for the domestic eye care market, announces that Avenova® Direct is available at affordable prici…
Acucela Receives Orphan Designation From the EMA for Emixustat for the Treatment of Stargardt Disease
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today that the European Medicines Agency (EMA) granted orphan des…
Global $673.2Mn Optical Lens Edgers Market Outlook Report, 2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Optical Lens Edgers Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018-2026” report has been added to ResearchAndMarkets.com’s offering. The global optical lens edgers market was valued at US$ 380.5 million in 2017 and is expected to reach US$ 673.2 million by 2026, expanding at a CAGR of 6.7% from 2018 to 2026. Key Market Movements Growing senescent population and increas
Global Vision Care Market 2019-2023 – Shift to E-commerce Platforms & Growing Preference for Daily Disposable Contact Lenses – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Vision Care Market: Size, Trends and Forecast (2019-2023)” report has been added to ResearchAndMarkets.com’s offering. Global Vision Care Market: Size, Trends and Forecast (2019-2023) provides an in-depth analysis of the vision care market including a detailed description of market sizing and growth. The report provides an analysis of the global vision care market by value and by segments. The report also includes a detailed segment analysis of the vision ca
Researchers Study Improvement in Patient Compliance and Screening Efficacy by Using the EyeArt AI Eye Screening System for Detecting Diabetic Retinopathy
LOS ANGELES–(BUSINESS WIRE)–Improvement in Patient Compliance and Screening Efficacy by Using the EyeArt AI Eye Screening System for Detecting Diabetic Retinopathy
International Study Confirms Significant, Sustained IOP and Medication Reduction Following Standalone Implantation of Glaukos’ iStent inject® in Glaucoma Patients with Substantial Disease Burden
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies desig…
Allegro Ophthalmics Announces Positive Topline Vision Results of Phase 2 Study Evaluating Risuteganib in Patients with Intermediate Dry Age-Related Macular Degeneration
SAN JUAN CAPISTRANO, Calif.–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/DME?src=hash" target="_blank">#DME</a>–Allegro Ophthalmics today announced positive topline results of its U.S. Phase 2 study of risuteg…
Eine der größten Diabetes-Klinken Deutschlands überprüft jährlich 20.000 Patienten mit AI-unterstütztem Augen-Screening-System EyeArt auf diabetische Retinopathie
LOS ANGELES–(BUSINESS WIRE)–Eine der größten Diabetes-Klinken Deutschlands überprüft jährlich 20.000 Patienten mit AI-unterstütztem Augen-Screening-System EyeArt auf diabetische
Fabrinet to Present at Upcoming Investor Conferences
BANGKOK–(BUSINESS WIRE)–Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, today announced tha…
Global Surgical Lasers Market to Surpass US$ 2 Billion by 2026 – Coherent Market Insights
SEATTLE–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/DiodeLaser?src=hash" target="_blank"gt;#DiodeLaserlt;/agt;–According to Coherent Market Insights, the global surgical lasers market was valued at US$ …
Aerie Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Aura Biosciences to Present at the Jefferies 2019 Global Healthcare Conference
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences today announced that CEO Elisabet de los Pinos, Ph.D., will present at the Jefferies 2019 Global Healthcare Conference.
Global Ophthalmology Market by Segment, Disease, Drug Class, and Region – Outlook to 2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmology Market by Segment, Disease, Drug Class, and Region – Outlook to 2025” report has been added to ResearchAndMarkets.com’s offering. Treatment paradigm of eye disorders primarily aims to reduce inflammation, repairs traumatic injuries, and improves or saves eyesight. Treatment comprises of medication, surgery, prescription glasses or contact lenses and treatment of systemic conditions affecting the eye. Prevalence of eye disorders has been increas
NovaBay Pharmaceuticals Receives NYSE American Communication
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova® for the domestic eye care market, announces that on May 16, 2019 it received notice …
最新科学研究显示，首尔半导体SunLike系列自然光谱LED可提升视觉舒适感、日间警觉性、情绪和睡眠深度
韩国安山–(BUSINESS WIRE)–最新科学研究显示，首尔半导体SunLike系列自然光谱LED可提升视觉舒适感、日间警觉性、情绪和睡眠深度